Control of the Functional Fate of CD4 T Cells by LncRNA-Switch
LncRNA-Switch 对 CD4 T 细胞功能命运的控制
基本信息
- 批准号:9170246
- 负责人:
- 金额:$ 53.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAntigensCD4 Positive T LymphocytesCD8B1 geneCellsChromatinColitisCytotoxic T-LymphocytesDNADefectEffector CellEnhancersEnterocytesEnvironmentEpigenetic ProcessEpithelialEpithelial CellsEpitheliumEquilibriumGATA3 geneGene ExpressionGene TargetingGenerationsGenetic TranscriptionGenomeHelper-Inducer T-LymphocyteImmuneImmune responseImmune systemImmunityIn VitroInflammationInflammatoryIntestinesInvadedKiller CellsLeadMHC Class II GenesMapsMediatingModelingMolecularNamesPathologyPathway interactionsPhenotypePlayPopulationProcessRegulationRegulatory T-LymphocyteRepressionResearch DesignRoleSeminalSiteSterilityStretchingSystemT-LymphocyteTechnologyTestingThymus GlandTimeTissuesUntranslated RNAbasecytotoxicdesignepigenomicsfunctional plasticitygenome-wideimmune functionin vivointestinal epitheliumloss of functionnovelpathogenprecursor cellpressureprogramspromoterthymocytetranscription factortranscriptomics
项目摘要
SUMMARY
Optimal immune regulation is essential at the mucosal epithelium of the intestine that separates the antigen-
rich gut lumen from the sterile inner core of the body. In addition to forming a physical barrier, the epithelium
also carries out vital digestive functions and any tissue damage, induced by invading pathogens or excessive
inflammation can jeopardize the integrity of this critical border. Consequently, the mucosal immune system is
faced with the unique challenge to provide optimal and immediate protection but also to do so with the least
damage to the tissue. This dilemma imposes a constant pressure for the immune cells to adjust their immune
function in a way that is compatible with a defensive role able to protect the mucosal border but not destroy it.
This is especially an issue for CD4 T helper (Th) cells, which have the potential to differentiate to Treg and
suppress protective immune responses or to inflammatory effector cells like the Th17 cells that can initiate
excessive inflammation and induce severe immune pathology. Recently, we discovered that mature CD4 T
cells that migrate to the intestinal epithelium adapt to the environment by functionally divert from their
suppressive or inflammatory Th fate but instead reprogram to become protective CD8-like cytotoxic effector
cells. The reprogramming of CD4 cells to cytotoxic T lymphocytes (CTL) is a critical process that adapts them
to the mucosal environment and defects in the reprogramming process lead to the generation of highly
inflammatory Th17 T cells that cause severe tissue destruction in the intestine. Although extremely important,
nothing is known about the molecular mechanism or factors that drive the reprogramming process in mature
CD4 T cells. Preliminary studies however lead to the discovery of a novel long non-coding RNA(LncRNA),
which we have called, Switch, because we found that it is uniquely expressed in CD4 CTL precursor cells but
more importantly because its expression directly associates with the switching-on of the Runx3-dependent CTL
gene transcription program and the switching-off of the RORγt- and Foxp3-controlled CD4 Th fates in in vitro-
and in vivo-activated mature CD4 T cells. In addition, we found that loss-of-function of Switch impaired the
reprogramming of CD4 Th cells to CTL and led to the accumulation of highly pathogenic Th17 T cells in the
intestine. These observations support a role for Switch as a “master regulator” of CD4 plasticity as well as a
critical controller of the mechanism to adapt the functional fate of mucosal CD4 T cells in a way that is
compatible with the unique challenges at the mucosal interface of the intestine. We propose here to elucidate
the molecular mechanisms by which this novel LncRNA, Switch, is able to function as a central hub for CD4 T
cell plasticity that stretches beyond the Th fates and re-directs mature CD4 T cells to the Runx3-controlled CTL
lineage fate while suppressing the alternative pathways that lead to functional differentiation of CD4 T cells into
inflammatory RORγt controlled Th17 cells or suppressive Foxp3-controlled Treg.
总结
最佳的免疫调节在分离抗原的肠粘膜上皮中是必不可少的-
从身体无菌的内部核心丰富的肠腔。除了形成物理屏障外,
也进行重要的消化功能和任何组织损伤,由入侵的病原体或过度诱导
炎症会危及这一关键边界的完整性。因此,粘膜免疫系统是
面临着独特的挑战,既要提供最佳和即时的保护,
对组织的损伤。这种困境给免疫细胞施加了持续的压力,以调整其免疫功能。
以与能够保护粘膜边界但不破坏它的防御作用相容的方式起作用。
这对于CD 4辅助性T(Th)细胞尤其是一个问题,其具有分化为Treg的潜力,
抑制保护性免疫反应或炎症效应细胞,如Th 17细胞,
过度炎症并诱导严重的免疫病理学。最近,我们发现成熟的CD 4 T细胞
迁移到肠上皮的细胞通过功能性地从它们的
而是重编程成为保护性CD 8样细胞毒性效应子
细胞CD 4细胞重编程为细胞毒性T淋巴细胞(CTL)是使其适应的关键过程
在重编程过程中的粘膜环境和缺陷导致产生高度
炎性Th 17 T细胞,导致肠道中严重的组织破坏。虽然非常重要,
目前还不清楚在成熟细胞中驱动重编程过程的分子机制或因素,
CD 4 T细胞。然而,初步研究发现了一种新的长非编码RNA(LncRNA),
我们称之为Switch,因为我们发现它只在CD 4 CTL前体细胞中表达,
更重要的是因为它的表达直接与Runx 3依赖性CTL的启动相关
基因转录程序和RORγt-和Foxp 3-控制的CD 4 Th命运的关闭
和体内活化的成熟CD 4 T细胞。此外,我们发现Switch功能的丧失损害了
CD 4 Th细胞重编程为CTL,并导致高致病性Th 17 T细胞在细胞中的积累。
肠子这些观察结果支持开关作为CD 4可塑性的“主调节器”以及CD 4可塑性的“主调节器”的作用。
调节粘膜CD 4 T细胞功能命运的机制的关键控制者,
与肠粘膜界面处的独特挑战相容。我们在此提议阐明
这种新的LncRNA,开关,能够作为CD 4 T细胞的中心枢纽的分子机制,
细胞可塑性,其延伸超出Th命运并将成熟的CD 4 T细胞重定向至Runx 3控制的CTL
同时抑制导致CD 4 T细胞功能性分化为
炎性RORγt控制的Th 17细胞或抑制性Foxp 3控制的Treg。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HILDE MC CHEROUTRE其他文献
HILDE MC CHEROUTRE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HILDE MC CHEROUTRE', 18)}}的其他基金
The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
- 批准号:
10331846 - 财政年份:2020
- 资助金额:
$ 53.55万 - 项目类别:
The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
- 批准号:
9888243 - 财政年份:2020
- 资助金额:
$ 53.55万 - 项目类别:
The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
- 批准号:
10552636 - 财政年份:2020
- 资助金额:
$ 53.55万 - 项目类别:
DIFFERENTIATION AND ANTI-VIRAL PROTECTIVE AND PATHOGENIC ROLES OF CD4 CTL
CD4 CTL 的分化、抗病毒保护和致病作用
- 批准号:
9246417 - 财政年份:2014
- 资助金额:
$ 53.55万 - 项目类别:
DIFFERENTIATION AND ANTI-VIRAL PROTECTIVE AND PATHOGENIC ROLES OF CD4 CTL
CD4 CTL 的分化、抗病毒保护和致病作用
- 批准号:
8655464 - 财政年份:2014
- 资助金额:
$ 53.55万 - 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
- 批准号:
8518428 - 财政年份:2009
- 资助金额:
$ 53.55万 - 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
- 批准号:
7846264 - 财政年份:2009
- 资助金额:
$ 53.55万 - 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
- 批准号:
8134362 - 财政年份:2009
- 资助金额:
$ 53.55万 - 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
- 批准号:
7939802 - 财政年份:2009
- 资助金额:
$ 53.55万 - 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
- 批准号:
8318169 - 财政年份:2009
- 资助金额:
$ 53.55万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 53.55万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 53.55万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 53.55万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 53.55万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 53.55万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 53.55万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 53.55万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 53.55万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 53.55万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 53.55万 - 项目类别: